Search the site

What are you looking for?

Technical Analysis Global FinanceStocks

JPMorgan Technical Analysis: $326 Support Faces a $344 Recovery Ceiling

AI

JPMorgan technical analysis starts with a contradiction that the next few sessions must resolve. The stock closed Friday, 23 October 2026, at $331.53, only 1.5% above a rising 200-day exponential moving average at $326.55, yet it finished below both the 20-day EMA at $336.12 and the 50-day EMA at $340.27. The long trend is still alive, but the fast trend is still leaning against it. A rebound from the 13 October low at $325.13 reached $344.37 and then failed. That sequence turns the same zone that protected the stock into a more demanding test: buyers have proved that they can defend the floor, but they have not proved that they can carry price back through supply.

JPMorgan daily chart with 20, 50 and 200 day EMAs, support at 325.13, resistance at 344.37, IEX volume and RSI
JPMorgan daily technical snapshot through 23 October 2026. Source: Alpaca Market Data, IEX feed; calculations by Block2Learn.

The tactical map is therefore compact. The first support cluster runs from roughly $325.13 to the 200-day EMA near $326.55. The first recovery barrier is the 20-day EMA at $336.12; the more important confirmation band sits between the 50-day EMA at $340.27 and the rebound high at $344.37. Above that band, the August peak at $366.30 returns as the major upside reference. Below support, the chart loses the structure that has separated a correction inside a broader advance from a genuine medium-term breakdown. Until one side wins, JPM is a range with asymmetric consequences rather than a clean trend trade.

Block2Learn
Live chart · Block2Learn analysis
NYSE:JPM1D
Market liveUTC · synchronizing
Loading TradingView chart…
Live market dataAsset and timeframe match this analysis
Interactive chart byTradingView

The JPMorgan chart in one table

MeasureReading through 23 Oct. 2026Technical meaning
Close$331.53Below the 20- and 50-day EMAs; above the 200-day EMA
20-day EMA$336.12First tactical resistance after Friday’s decline
50-day EMA$340.27Intermediate trend barrier and supply zone
200-day EMA$326.55Rising long-trend support, close to the October low
14-day RSI41.2Momentum repaired from oversold pressure, but remains below neutral 50
MACD histogram+0.75Recovery impulse remains positive but is shrinking
14-day ATR$6.16Typical daily movement equals about 1.86% of price
20-day range$325.13–$344.37Current decision range
63-day range$325.13–$366.30Correction nested inside a wider distribution
20-day average IEX volume257,824 sharesCurrent IEX volume context, not consolidated market volume

These levels are calculated from unadjusted daily OHLCV data from the Alpaca IEX feed. The latest IEX close of $331.53 was independently consistent with the broader-market quote near $331.58. IEX volume is useful for comparing activity within the same feed, but it is not the consolidated tape; it should be read as a relative participation signal rather than the full day’s share count.

What changed since the early-October support test

The previous JPMorgan technical analysis framed $325.94–$330.63 as the support zone that could decide whether the pullback remained orderly. At the time, JPM closed at $332.28, the 20-day EMA stood at $341.85, the 50-day EMA at $344.96, and the 200-day EMA at $325.25. Momentum was weak, with RSI near 34, and the chart had not yet delivered a decisive test of the long average.

The market has now supplied that missing evidence. Price fell to $325.13 on 13 October, almost exactly where the rising 200-day EMA and the previously mapped floor converged. Buyers responded immediately. Over the next several sessions, JPM recovered to $344.37, a move of roughly 5.9% from low to high. That bounce was large enough to repair short-term momentum, lift RSI away from oversold territory, and turn the MACD histogram positive. It was not large enough to secure a sustained close above the declining fast averages.

That distinction matters. A successful support test answers only the first question: whether demand exists near the floor. It does not answer the second: whether demand can absorb the supply waiting overhead. The rejection from $344.37 says that sellers remain active where the 20- and 50-day averages are converging. Friday’s fall back to $331.53 returned price to the lower half of the range and reduced the margin above the 200-day EMA. The chart is not where it was on 6 October. It has tested the floor, staged a rebound, and failed its first recovery attempt. The next move can therefore be judged against observed reactions rather than hypothetical levels.

Market structure: a correction that has not yet become a breakdown

The daily structure still contains two different trends. Over a full year, JPM remains positive: the 252-session return is approximately 12.7%, the 126-session return is about 7.5%, and the year-to-date return is roughly 1.9%. The 200-day EMA is rising, and price remains above it. Those facts describe an intact long-term advance that has lost speed, not a completed secular reversal.

The intermediate structure is less constructive. JPM is down about 6.9% over 63 sessions and 3.3% over 20 sessions. The August high at $366.30 has not been challenged again. Each recovery attempt since that peak has encountered supply, while the 20-day EMA has rolled beneath the 50-day EMA. Price now sits 1.4% below the 20-day average and 2.6% below the 50-day average. This is the geometry of a correction: the long average rises underneath price while the faster averages descend above it.

That compression cannot continue indefinitely. If the long trend continues to rise while the fast trends fall, the available space contracts. Either buyers reclaim the fast averages and reopen the route toward the old high, or sellers force a decisive close beneath the 200-day EMA and convert a compressed correction into a broader breakdown. The narrowness of the present decision zone is why a move of only a few percentage points can change the chart’s character.

Why the $325–$327 support zone is decisive

The $325.13 low is more than an isolated print. It aligns with the rising 200-day EMA at $326.55, the lower edge of October’s trading range, and the support band mapped before the earnings release. Multiple independent references clustering in the same area create a more credible decision zone than a single horizontal line.

There are three ways to judge that support. First is the closing basis. Intraday movement below the average can be noise, particularly when ATR is about $6.16. A close below $325.13 would carry more information than a brief undercut because it would show that demand failed to recover the range before the bell. Second is follow-through. One close beneath support can become a false break; two or more sessions holding below it, especially with expanding participation, would make the damage harder to dismiss. Third is the character of any retest. If price breaks $325 and then rallies back only to stall beneath $326–$330, former support has become supply.

The 200-day EMA should not be treated as a magical barrier. Its value comes from the behavior it organizes. Funds, systematic strategies, and discretionary traders often use the long average as a common reference, which can concentrate orders around it. A rising average also means the reference is moving. By next week, the exact number will be different, so the practical zone matters more than a one-cent precision. What matters is whether JPM continues to build closes above the average and whether rebounds from it produce higher highs.

The $336–$344 recovery ceiling

The first obstacle is the 20-day EMA at $336.12. Friday’s close left JPM about $4.59 beneath it, less than one ATR. That makes a retest feasible in a single energetic session, but touching the average is not the same as reclaiming it. Buyers need a close above $336.12 and then evidence that the average can support a pullback.

The next barrier is the 50-day EMA at $340.27. It is the more meaningful trend filter because it has flattened and turned down while price remains below it. A close above the 50-day average would reduce the immediate bearish pressure, yet the rebound high at $344.37 still marks the supply that stopped the most recent advance. The recovery ceiling is therefore a band, not one number: approximately $340.27–$344.37.

This band is roughly 2.6% to 3.9% above Friday’s close. With ATR near 1.86% of price, the entire distance is tradable but not trivial. A one-day surge could enter the zone; a sustained reversal would need acceptance above it. The highest-quality bullish confirmation would be a close through $344.37 followed by a shallow pullback that holds above the 50-day EMA. That sequence would replace the latest lower high with a higher low and higher high, improving both momentum and structure.

The low-quality version is a sharp intraday spike that closes back below $340. That would repeat the current pattern: enthusiasm into overhead supply, followed by rejection. Traders should distinguish the excitement of reaching resistance from the evidence of clearing it.

Momentum: repaired, but not yet persuasive

The 14-day RSI stands near 41.2. This is a meaningful improvement from the mid-30s seen before the support test, but it remains below the neutral 50 line. RSI is therefore consistent with a bearish-to-neutral regime rather than a fresh positive trend. It says selling pressure has cooled; it does not say buyers control the tape.

The shape of RSI matters as much as the reading. It rose toward 50 during the bounce to $344.37 and then turned lower as price was rejected. If the next support test produces a higher RSI low while price holds near $325–$327, that positive divergence would suggest that sellers are expending more effort for less progress. If RSI breaks below its October trough as price loses support, momentum would instead confirm the breakdown.

MACD offers a similarly mixed message. The MACD line remains below zero, but the histogram is positive at about +0.75. The positive histogram shows that downside momentum has decelerated and the faster line has moved above its signal line. However, the histogram has already contracted from roughly +1.05 in the prior session. A shrinking positive histogram below the zero line often describes an incomplete recovery: momentum improved from a weak base, but the improvement is losing force before the underlying trend has turned.

For a durable bullish shift, watch for MACD to continue higher toward zero while price closes above the 50-day EMA. If the histogram flips negative while JPM remains below the 20-day EMA, it would align momentum with the latest price rejection and raise the probability of another support test.

Volatility and the meaning of the range

The 14-day ATR of $6.16 translates to approximately 1.86% of price. That reading provides a scale for the levels. The distance from Friday’s close to the 200-day EMA is only about $4.98, or 0.8 ATR. The distance to the 20-day EMA is about $4.59, also near 0.75 ATR. JPM is therefore positioned almost exactly between its first support and first resistance in volatility-adjusted terms.

The 20-day Bollinger Bands reinforce that compression. The middle band is near $333.70, the upper band near $338.52, and the lower band near $328.88. Friday closed below the middle band and only modestly above the lower band. A recovery above the midpoint would put price back into the upper half of the short-term distribution. A close below the lower band, particularly if the band begins expanding, would show that volatility is being released to the downside.

The bands should not be used as automatic reversal points. In strong trends, price can walk a band. Their value here is contextual: the lower band, the 200-day EMA, and the October low all occupy the same neighborhood. If that cluster fails together, the move is more significant than a routine lower-band touch.

Participation: use the IEX volume signal carefully

Friday’s IEX volume was 120,711 shares, about 47% of its 20-day average within the same feed. That muted reading does not confirm aggressive distribution. It also does not erase the price decline, because IEX represents only one venue and not the consolidated U.S. market. The broad-market quote showed materially more total volume, as expected.

The useful comparison is internal and directional. A breakout through $344.37 accompanied by IEX activity above its 20-day average would show that participation expanded as resistance gave way. A break below $325.13 on similarly elevated activity would confirm the opposite. Low-volume tests are more vulnerable to reversal because fewer participants have accepted the new price. High-volume acceptance, especially over more than one session, carries more weight.

Earnings strength versus a cautious chart

JPMorgan’s fundamentals explain why the 200-day average still attracts buyers, but they do not override the chart. On 13 October, the company reported third-quarter 2026 net income of $15.3 billion and diluted earnings per share of $5.57. Excluding a significant item, management reported net income of $15.8 billion and EPS of $5.75. Managed revenue was $50.9 billion, while the standardized CET1 capital ratio was estimated at 13.9%. The figures are available in the company’s third-quarter earnings release and the filed SEC Form 8-K.

Those results are strong enough to support the long-term narrative. Net interest income benefited from higher deposit balances, and the franchise retains scale across consumer banking, payments, markets, and asset management. But price action shows that investors are also discounting the path ahead: deposit pricing, funding costs, credit normalization, capital requirements, and the rate environment can all affect how much of current earnings power deserves to be capitalized.

That is why the chart can remain cautious immediately after solid earnings. Fundamentals determine the broad field of possibilities; price reveals which possibilities the marginal buyer and seller are emphasizing now. The failed recovery to $344.37 shows that the earnings reaction did not produce sustained technical acceptance above the fast averages.

Our broader discussion of the U.S. bank earnings rate test explains why the sector is especially sensitive to the interaction between margins, deposits, loan growth, and the yield curve. JPM’s chart is a compressed expression of that same debate.

The Federal Reserve is the next volatility catalyst

The Federal Reserve’s official FOMC calendar lists the next policy meeting for 27–28 October 2026. That event sits immediately ahead of the current decision range. For a money-center bank, the market’s interpretation of the rate path can influence net-interest-margin expectations, trading conditions, credit spreads, and valuation multiples at the same time.

The relevant question is not merely whether the policy rate changes. Markets will parse the statement and press conference for the expected pace of future moves, the balance between inflation and employment risks, and the committee’s tolerance for financial-condition shifts. A steeper curve can help parts of bank profitability, but the reason for the steepening matters. Growth optimism and term-premium stress do not produce the same credit or valuation outcome.

Readers can monitor the official Treasury interest-rate statistics for the closing par-yield curve. The related Market Focus on oil-driven rate divergence provides the macro backdrop: commodity pressure, inflation expectations, and divergent policy paths can alter financial conditions quickly. For JPM, that macro event risk argues for waiting for closing confirmation rather than anticipating a breakout inside the range.

Scenario map for the next move

Bullish scenario: reclaim and hold above $344.37

The bullish path begins with a close above the 20-day EMA, then the 50-day EMA, and finally the rebound high at $344.37. The order matters because each step removes a different layer of resistance. A single close above $344.37 would improve the chart, but a retest that holds $340–$344 would provide stronger evidence that supply has been absorbed.

If that confirmation appears, the next reference is the mid-$350s, where the August–September distribution produced repeated congestion. Beyond it, $366.30 is the major 63-day and 126-day high. A return there would represent roughly 10.5% upside from Friday’s close. The bullish thesis is invalidated if the breakout immediately fails and price closes back beneath the 50-day EMA, because that would turn apparent strength into another rejection.

Neutral scenario: continued rotation between $325 and $344

The base case is continued range trade. ADX near 17.7 indicates weak trend strength, with minus directional movement only modestly above plus directional movement. That configuration favors mean reversion until price proves otherwise. In this scenario, the 200-day EMA attracts bids, the fast averages attract sellers, and the stock oscillates without closing beyond the range.

A neutral range is not inactivity. It can include large daily moves because ATR is elevated enough to produce six-dollar sessions. The defining feature is that those moves fail to create acceptance outside $325.13–$344.37. For swing traders, the center near the Bollinger midpoint offers poor reward relative to either edge. For longer-term observers, the range is an information-gathering phase: watch whether lows become higher, whether the fast averages flatten, and whether participation expands on up days or down days.

Bearish scenario: acceptance below $325.13

The bearish case requires more than an intraday break. A close below $325.13 and the 200-day EMA, followed by failure to reclaim the zone, would change the medium-term structure. The first downside reference would be the psychological $320 area and the late-spring congestion below it. The next major structural level is the 126-day low near $293.83, though price would encounter intermediate support before reaching that distant marker.

The strongest bearish confirmation would combine three signals: a close below support, an RSI break toward or through 30 without positive divergence, and expanding participation. If those elements align, the October bounce can be reclassified as a failed recovery within a downtrend rather than a successful long-term support test. The bearish thesis weakens quickly if price undercuts $325 but closes back above the 200-day EMA and then reclaims $336. That would resemble a liquidity sweep rather than durable acceptance lower.

A disciplined long setup

An evidence-led long setup has two possible entries. The conservative version waits for a daily close above $344.37 and a successful retest of the $340–$344 band. The trigger is acceptance, not merely a high above resistance. A logical invalidation sits beneath the retest low or beneath the 50-day EMA, depending on volatility and time horizon. Initial objectives are the mid-$350s and then $366.30.

The aggressive version operates near support. It requires a clear bullish reversal around $325–$327, such as a failed breakdown followed by a close back above the 200-day EMA, ideally with RSI holding above its prior low. Because this entry acts before trend confirmation, position size must reflect the higher probability of being wrong. Invalidation belongs beneath the reversal low, not at an arbitrary percentage. The first objective is the 20-day EMA, followed by the 50-day EMA and $344.37.

In both cases, reward should be measured in ATR units as well as dollars. A stop less than one ordinary daily range from entry can be vulnerable to normal noise. A wider stop without a smaller position can create excessive risk. The setup improves when the chosen invalidation is structurally meaningful and the position is sized around that distance.

A disciplined short setup

The cleanest short setup is a confirmed breakdown below $325.13. A trader could wait for a close beneath the zone and then a weak retest that fails under the 200-day EMA. That sequence places invalidation above the reclaimed support band and avoids selling the first intraday probe. The initial objective is the next congestion area near $320, with subsequent objectives determined by the structure that forms after the break.

An alternative short appears at the recovery ceiling if JPM rallies into $340–$344 and produces another rejection with deteriorating momentum. This is a range trade rather than a trend confirmation, so it carries different risk. The invalidation belongs above $344.37 and the rejection high. The first objective is the Bollinger midpoint or $336 area, followed by the 200-day EMA. If price instead closes and holds above $344.37, the short thesis has failed.

No setup is strengthened by moving its invalidation after the chart has contradicted the original premise. The technical level defines the thesis; the position size adapts to the level.

What to watch each day

The most efficient daily checklist is short. First, note whether JPM closes above or below the 20-day EMA. That tells us whether the recovery has regained its first layer. Second, track the slope and location of the 50-day EMA. A flattening average with price above it would show intermediate repair; a falling average that repeatedly rejects price would keep the correction intact. Third, compare the close with the 200-day EMA and $325.13 floor. Fourth, watch RSI around 50 and MACD histogram direction. Fifth, compare same-feed IEX volume with its 20-day average, while remembering that it is not consolidated volume.

Finally, align technical evidence with the event calendar. A pre-FOMC breakout on muted participation deserves less confidence than a post-meeting move that holds through the close and receives follow-through. The calendar can explain when volatility is likely to rise; the chart still decides whether that volatility produced acceptance or rejection.

For readers building the underlying framework, the Block2Learn Learning Path connects trend, momentum, volatility, and risk sizing into one process. The goal is not to predict every candle. It is to know what evidence would strengthen or invalidate each scenario before the market supplies it.

Bottom line

JPMorgan’s 13 October low confirmed that real demand exists around $325–$327. The rebound to $344.37 confirmed that meaningful supply still exists above the fast averages. Friday’s close at $331.53 places the stock between those two proven reactions, below the 20- and 50-day EMAs but above the rising 200-day EMA.

That makes the next signal unusually clear. A close and hold above $344.37 would complete the first credible recovery sequence and reopen the path toward the mid-$350s and $366.30. Acceptance below $325.13 would break the support structure and put the broader correction on a more bearish footing. Continued closes inside the range favor patience and smaller expectations.

The floor held. The recovery did not. Now the chart must show which side can turn a reaction into control.

Stay curious. Stay cautious. Stay invested.

This article is provided solely for informational and educational purposes and does not constitute financial or investment advice, a recommendation, or an offer or solicitation to buy or sell any financial instrument or digital asset. See our Financial Disclaimer.

This article was generated with the support of AI and reviewed by the Editorial Team. For more information, see our Terms of Service.

Your investor workspace. One free account. Track your portfolio, organize your investment tools, follow the markets and access Block2Learn from one personal dashboard. PORTFOLIO ◆ MARKET ANALYSIS ◆ AI & TOOLS ◆ LEARNING
15%OFFYOUR WELCOME BONUS Register and receive your 15% welcome discount code by email. Use it on your first purchase: a Learning Path course or a Block2Learn PRO subscription.
CREATE YOUR FREE ACCOUNT

You Missed

Discover more from Block2Learn

Subscribe now to keep reading and get access to the full archive.

Continue reading